| RS2544389456 |
KIAA0753
|
Health Risk |
Pathogenic |
— |
| RS2544389543 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544389679 |
ACTG1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS2544389682 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2544389713 |
ACTG1
|
Health Risk |
Likely pathogenic |
— |
| RS2544389796 |
KIAA0753
|
Health Risk |
Likely pathogenic |
— |
| RS2544389952 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS2544389996 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544390077 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2544390320 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2544390432 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2544390528 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2544390554 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2544390572 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2544390610 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2544391908 |
CIITA
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2544392103 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS2544392140 |
ACTG1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS2544392281 |
ACTG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS2544392831 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS2544393217 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544393267 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS2544393285 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 20, ACTG1-related disorder |
| RS2544393343 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2544393388 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544393411 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2544393489 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544395061 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2544395103 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2544395257 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2544395419 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2544397166 |
PSMB10
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 5, Proteasome-associated autoinflammatory syndrome 5 |
| RS2544397242 |
CBFB
|
Health Risk |
Pathogenic |
Cleidocranial dysplasia 2, Cleidocranial dysplasia 2 |
| RS2544397939 |
CCDC88C
|
Health Risk |
Pathogenic |
— |
| RS2544398205 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544398331 |
CCDC88C
|
Health Risk |
Pathogenic |
— |
| RS2544398828 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2544399189 |
PSMB10
|
Health Risk |
Pathogenic |
Immunodeficiency 121 with autoinflammation, Immunodeficiency 121 with autoinflammation |
| RS2544400695 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2544401055 |
CIITA
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2544401345 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544401818 |
TSC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2544402252 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2544402748 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS2544403082 |
LCAT
|
Health Risk |
Pathogenic |
— |
| RS2544404975 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2544405181 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2544405202 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544405335 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544405582 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2544405667 |
LCAT
|
Health Risk |
Likely pathogenic |
— |
| RS2544405809 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544405828 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2544405849 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544405868 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544405872 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2544405929 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2544406616 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2544406643 |
LCAT
|
Health Risk |
Likely pathogenic |
Norum disease, Norum disease |
| RS2544409249 |
KIAA0753
|
Health Risk |
Pathogenic |
— |
| RS2544410051 |
KIAA0753
|
Health Risk |
Pathogenic |
— |
| RS2544411002 |
LCAT
|
Health Risk |
Pathogenic |
— |
| RS2544414231 |
CCDC88C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hydrocephalus, nonsyndromic |
| RS2544415250 |
CIITA
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2544421074 |
PPM1D
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2544421308 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS2544422008 |
FKBP10
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 12, Osteogenesis imperfecta type 12 |
| RS2544427042 |
OTOP2;USH1G
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2544427211 |
USH1G
|
Health Risk |
Pathogenic |
— |
| RS2544427345 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS2544427492 |
USH1G
|
Health Risk |
Pathogenic |
— |
| RS2544428980 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2544431166 |
USH1G
|
Health Risk |
Likely pathogenic |
USH1G-related disorder, USH1G-related disorder |
| RS2544431739 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS2544432008 |
USH1G
|
Health Risk |
Pathogenic |
— |
| RS2544432143 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency 1, MHC class II deficiency 1 |
| RS2544432408 |
CIITA
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2544433461 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS2544434003 |
FKBP10
|
Health Risk |
Likely pathogenic |
Bruck syndrome 1, Osteogenesis imperfecta type 11 |
| RS2544435210 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS2544435572 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS2544436900 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS2544436967 |
FKBP10
|
Health Risk |
Likely pathogenic |
— |
| RS2544437740 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS2544440342 |
PPM1D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2544444797 |
NEK8
|
Health Risk |
Likely pathogenic |
Nephronophthisis 9, Nephronophthisis 9 |
| RS2544446785 |
FKBP10
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 11, Osteogenesis imperfecta type 11 |
| RS2544446810 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS2544448905 |
FSCN2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2544454642 |
DNAH9
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS2544463573 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2544465676 |
PPM1D
|
Health Risk |
Pathogenic |
Familial cancer of breast, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2544465726 |
PPM1D
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2544465797 |
PPM1D
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2544467143 |
CCDC88C
|
Health Risk |
Pathogenic |
— |
| RS2544468139 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2544468802 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2544469389 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2544469716 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2544469783 |
PPM1D
|
Health Risk |
Pathogenic |
— |